Clinical Research

Paradigm Biopharmaceuticals (USA) Inc.

Address
31 West 34th Street

Sponsor Overview

assignment
2
sponsored trials
science
3
molecules
location_city
6
research centres
public
3
countries
person_search
6
investigators

Specializations

Musculoskeletal Pain in Knee Osteoarthritis

Paradigm Biopharmaceuticals (USA) Inc. focuses on clinical research in knee osteoarthritis pain, with attention to pain burden and functional limitation associated with degenerative joint disease.

  • Knee pain
  • Joint function
  • Osteoarthritis-related symptoms

The sponsor’s trial activity is centered on therapeutic evaluation in participants with symptomatic knee osteoarthritis.

Analgesic Therapy

Its research portfolio includes treatment-focused studies aimed at improving pain relief and daily mobility in people affected by chronic osteoarthritic pain.

  • Pain management
  • Mobility outcomes
  • Functional improvement

The therapeutic interest is directed toward interventions for persistent musculoskeletal discomfort and reduced physical performance.

Inflammatory Joint Disease

The sponsor’s clinical work also aligns with research into joint degeneration and the symptom profile of osteoarthritis, particularly where inflammation and structural wear contribute to pain.

  • Degenerative joint disease
  • Articular symptoms
  • Chronic joint discomfort

These studies reflect interest in therapies for the symptomatic management of lower-limb osteoarthritis.

Sponsored Trials

Trial Name Country Status
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis PainBelgium BelgiumNot Yet Recruiting
Evaluation of Pentosan Polysulfate Sodium in a drug combination for adults with knee osteoarthritis painBelgium BelgiumCzechia CzechiaPoland PolandNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 3 total (33% not shared with other sponsors)

This sponsor works with 3 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
17%
Return partnership rate
1 of 6 sites collaborated multiple times

This sponsor has worked with 6 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Musculoskeletal Diseases2 trials
    238 other sponsors

Partnered Research Centres

6 centres
location_city
assignment42
Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A.
Address
Ul. 1 Maja 13 C, 10-117 Olsztyn
Learn morearrow_forward
location_city
assignment1165
Katholieke Universiteit te Leuven
Address
Herestraat 49, 3000 Leuven
Learn morearrow_forward
location_city
assignment56
Medical Plus s.r.o.
Address
Obchodni 1507, 686 01 Uherské Hradiště
Learn morearrow_forward
location_city
assignment30
Pratia Brno s.r.o.
Address
Hybešova 258/20, 602 00 Brno-střed
Learn morearrow_forward
location_city
assignment7
Revmaclinic s.r.o.
Address
Zamecnicka 87/1, Brno-Mesto, 602 00 Brno-střed
Learn morearrow_forward
location_city
assignment11
Tomasz Blicharski Lubelskie Centrum Diagnostyczne
Address
Ul. Drewniana 61, 21-040 Swidnik
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Paradigm Biopharmaceuticals (USA) Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.